📰 Session Date News
Page 2 - Session Date News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Session Date. Real-time updates on events, politics, business and more.
May 25, 2023
- Nirogacestat Treatment Demonstrated Rapid, Sustained and Consistent Reductions in Pain Compared to Placebo Using Multiple Assessment Tools - - Substantial Reductions in MRI-Assessed Tumor Volume... | May 25, 2023
May 8, 2023
/PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for...
May 2, 2023
LEXINGTON, Mass. and AMSTERDAM, May 02, 2023(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that 12 data presentations
May 2, 2023
LEXINGTON, Mass. and AMSTERDAM, May 02, 2023 -- uniQure N.V. , a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that 12 data... | May 2, 2023
April 26, 2023
/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...
April 19, 2023
Tango Therapeutics, Inc. announced highlights from presentations at the American Association for Cancer Research 2023 Annual Meeting, taking place from April 14-19, 2023 in Orlando, Florida. Tango... | April 19, 2023
November 30, 2022
Data from first two dose levels of Nana-val in patients with EBV+ recurrent/metastatic nasopharyngeal carcinoma support continued dose escalation to...
November 28, 2022
Epygenix Therapeutics, a clinical-stage biopharmaceutical company focused on discovering and developing therapies for rare and intractable forms of genetic
November 7, 2022
70% objective response rate (ORR; n=10) is nearly triple the average ORR of ~25% reported in historical control trials1-4 Data suggest pelareorep synergizes...
October 26, 2022
NEWARK, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage company developing precision oncology...